Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins

被引:334
|
作者
Flynn, SW
Lang, DJ
Mackay, AL
Goghari, V
Vavasour, IM
Whittall, KP
Smith, GN
Arango, V
Mann, JJ
Dwork, AJ
Falkai, P
Honer, WG [1 ]
机构
[1] Univ British Columbia, Ctr Complex Disorders, Dept Psychiat, Vancouver, BC V5Z 1L8, Canada
[2] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada
[3] Columbia Univ, Dept Psychiat, New York, NY USA
[4] Columbia Univ, Dept Pathol, New York, NY USA
[5] New York State Psychiat Inst & Hosp, Dept Neurosci, New York, NY 10032 USA
[6] Univ Saarland, Dept Psychiat, D-6650 Homburg, Germany
关键词
myelin-associated glycoprotein; 2; 3 '-cyclic nucleotide 3 '-phosphodiesterase; frontal lobe; T2; relaxation; schizophrenia; oligodendrocyte;
D O I
10.1038/sj.mp.4001337
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Schizophrenia unfolds during the late period of brain maturation, while myelination is still continuing. In the present study, we used MRI and T2 relaxation analysis to measure the myelin water fraction in schizophrenia. In schizophrenia ( n = 30) compared with healthy subjects ( n = 27), overall white matter showed 12% lower myelin water fraction ( P = 0.031), with the most prominent effects on the left genu of the corpus callosum (36% lower, P = 0.002). The left anterior genu was affected in both first-episode (P = 0.035) and chronic patients (P = 0.011). In healthy subjects, myelin water fraction in total white matter and in frontal white matter increased with age, and with years of education, indicating ongoing maturation. In patients with schizophrenia, neither relation was statistically significant. Post-mortem studies of anterior frontal cortex demonstrated less immunoreactivity of two oligodendrocyte-associated proteins in schizophrenia (2',3'-cyclic nucleotide 3'-phosphodiesterase by 33%, P = 0.05; myelin-associated glycoprotein by 27%, P = 0.14). Impaired myelination in schizophrenia could contribute to abnormalities of neural connectivity and persistent functional impairment in the illness.
引用
下载
收藏
页码:811 / 820
页数:10
相关论文
共 50 条
  • [21] POST-MORTEM LABILITY OF SKELETAL MUSCLE PROTEINS
    SCOPES, RK
    LAWRIE, RA
    NATURE, 1963, 197 (487) : 1202 - &
  • [22] POST-MORTEM CHANGES IN MUSCLE PLASMA PROTEINS
    WIERBICKI, E
    DEATHERAGE, FE
    JOURNAL OF ANIMAL SCIENCE, 1954, 13 (04) : 973 - 973
  • [23] MRI autopsy: A Suitable Alternative for Post-Mortem Analysis of the Foetal CNS?
    Jacobs, R. S.
    Kong, W. M.
    Hazell, S.
    Osborn, M. R.
    JOURNAL OF PATHOLOGY, 2012, 226 : S8 - S8
  • [24] STATUS OF THE DOPAMINERGIC SYSTEM IN POST-MORTEM BRAIN IN SCHIZOPHRENIA
    REYNOLDS, GP
    CZUDEK, C
    PSYCHOPHARMACOLOGY BULLETIN, 1988, 24 (03) : 345 - 347
  • [25] Altered glutamatergic receptors in schizophrenia: A post-mortem study
    Corti, C.
    Crepaldi, L.
    Corsi, M.
    Xuereb, J. H.
    Ferraguti, F.
    NEUROPHARMACOLOGY, 2008, 55 (04) : 593 - 593
  • [26] The mediodorsal nucleus of the thalamus in schizophrenia: A post-mortem study
    Cullen, TJ
    Walker, MA
    Roberts, H
    Crow, TJ
    Harrison, P
    Esiri, M
    SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 5 - 5
  • [27] Post-mortem correlates of disturbed cerebral asymmetry in schizophrenia
    Falkai, P
    Vogeley, K
    Bogerts, B
    ONE WORLD, ONE LANGUAGE: PAVING THE WAY TO BETTER PERSPECTIVES FOR MENTAL HEALTH, 1999, : 225 - 227
  • [28] Post-Mortem MRI Comparison with Traditional Post-Mortem Examination: Lessons Learned from the First Year in Practice
    Ramsey, M. C.
    Downey, P.
    Lehane, C.
    Colleran, G.
    JOURNAL OF PATHOLOGY, 2019, 248 : S6 - S6
  • [29] Post-mortem brain weight in schizophrenia and affective disorder
    Bigelow, LB
    Torrey, EF
    SCHIZOPHRENIA RESEARCH, 1998, 29 (1-2) : 85 - 85
  • [30] Correlation analysis of in vivo MRI and post-mortem quantitative immunohistochemistry data in a mouse model of inflammatory cerebral demyelination
    Zehntner, S. P.
    Zijdenbos, A. P.
    Bedell, B. J.
    Cadavid, D.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 304 - 304